AKIRIN2 and cholangiocarcinoma: To validate that Akirin2 is a potential angiogenesis driver in CCA cells, conditioned media derived from Akirin2 overexpressing and downregulated CCA cells were used to examine their effects on the ability of human umbilical vein endothelial cells (HUVECs) to migrate and form tubes.